Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XARA: Xeomin in pediatric cerebral palsy spasticity
NCT02002884Phase 3Completed
- Sponsor
- Merz
- Start
- Mar 2014
- Primary completion
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 3 trial of incobotulinumtoxinA in spasticity, sponsored by Merz. Started Mar 2014; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT02002884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02002884.